Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · IEX Real-Time Price · USD
8.11
-0.89 (-9.94%)
At close: Jul 2, 2024, 4:00 PM
8.43
+0.32 (4.01%)
After-hours: Jul 2, 2024, 4:46 PM EDT
Tango Therapeutics Employees
Tango Therapeutics had 140 employees as of December 31, 2023. The number of employees increased by 30 or 27.27% compared to the previous year.
Employees
140
Change (1Y)
30
Growth (1Y)
27.27%
Revenue / Employee
$265,943
Profits / Employee
-$797,500
Market Cap
865.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 140 | 30 | 27.27% |
Dec 31, 2022 | 110 | 19 | 20.88% |
Dec 31, 2021 | 91 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
TNGX News
- 27 days ago - Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire
- 5 weeks ago - Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program - PRNewsWire
- 5 weeks ago - Tango Therapeutics to stop development of cancer therapy - Reuters
- 5 weeks ago - Tango Therapeutics Announces Discontinuation of TNG348 Program - Business Wire
- 7 weeks ago - Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights - Business Wire
- 3 months ago - Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights - Business Wire
- 4 months ago - Tango Therapeutics to Participate in Upcoming Investor Conferences - Business Wire